HPV vaccine acceptability in Ghana, West Africa

Vaccine

Volumn 29, Issue 23, 2011, Pages 3945-3950

  Coleman, Maame Aba ^a   Levison, Judy ^a   Sangi Haghpeykar, Haleh ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Acceptability; Cervical cancer; HPV vaccine; West Africa

Indexed keywords

WART VIRUS VACCINE;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DRUG COST; EDUCATION PROGRAM; FEMALE; GHANA; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; NEEDLE; PAPANICOLAOU TEST; PRIORITY JOURNAL; SOCIAL SUPPORT; UTERINE CERVIX CANCER; VACCINATION; WART VIRUS;

ADOLESCENT; ADULT; AGED; FEMALE; GHANA; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; UTERINE CERVICAL NEOPLASMS; VACCINATION; VAGINAL SMEARS; YOUNG ADULT;

EID: 79955664086     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.03.093     Document Type: Article

References (25)

1. Parkin D.M., Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine 2006, 24(Suppl 3):S311-S325.
2. Parkin D.M., Ferlay J., Hamdi-Cherif M., Sitas F., Thomas J.O., Wabinga H., et al. Cancer in Africa: epidemiology and prevention. 4.3 Cervix Cancer. IARC Scientific Publications; No. 153 2003, IARC Press, Lyon, p. 268-76.
3. Parkin D.M., Whelan S.L., Ferlay J., Thomas D.B., Teppo L. Cancer incidence in five continents. IARC Scientific Publications; No. 155 2002, IARC press, Lyon.
4. International Agency for Research on Cancer. Globocan 2002. Available from: http://www-dep.iarc.fr/.
5. Domfeh A.B., Wiredu E.K., Adjei A.A., Ayeh-Kumi P.F.K., Adiku T.K., Tet-Tey Y., et al. Cervical human papillomavirus infection in Accra, Ghana. Ghana Med J 2008, 42(2):71-78.
6. Abotchie P.N., Shokar N.K. Cervical cancer screening among college students in Ghana: knowledge and health beliefs. Int J Gynecol Cancer 2009, 19(3):412-416.
7. Herzog T.J., Huh W.H., Downs L.D., Smith J.S., Monk B.J. Initial lessons learned in HPV vaccination. Gynecol Oncol 2008, 109(Suppl 2):S4-11.
8. Katahoire R.A., Jitta J., Kivumbi G., Murokora D., Arube W.J., Siu G., et al. An assessment of the readiness for introduction of the HPV vaccine in Uganda. Afr J Reprod Health 2008, 1293:159-172.
9. Harries J., Moodley J., Barone M.A., Mall S., Sinanovic E. Preparing for HPV vaccination in South Africa: key challenges and opinions. Vaccine 2009, 27(1):38-44.
10. Becker-Dreps S., Otieno W.A., Brewer N.T., Agot K., Smith J.S. HPV vaccine acceptability among Kenyan women. Vaccine 2010, 28:4864-4867.
11. Agosti J.M., Goldie S.J. Introducing HPV vaccine in developing countries: key challenges and issues. N Engl J Med 2007, 356(19):1908-1910.
12. Goldie S.J., O'Shea M., Diaz M., Kim S.Y. Benefits, cost requirements and cost-effectiveness of the HPV 16, 18 vaccine for cervical cancer prevention in developing countries: policy implications. Reprod Health Matter 2009, 16(32):86-96.
13. Bingham A., Drake J.K., LaMontagne S. Socio-cultural issues in the introduction of human papillomavirus vaccine in low-resource settings. Arch Pediatr Adolesc Med 2009, 163(5):455-461.
14. Louie K.S., de Sanjose S., Mayaud P. Epidemiology and prevention of human papillomavirus and cervical cancer in Sub-Saharan Africa: a comprehensive review. Trop Med Int Health 2009, 14(10):1287-1302.
15. Rosenstock I. Historical origins of the health belief model. Health Educ Monogr 1974, 2(4):328-335.
16. Janz N.K., Becker M.H. The health belief model: a decade later. Health Educ Q 1984, 11(1):1-47.
17. http://www.unicef.org/infobycountry/ghana_statistics.html.
18. Sundstrom K., Tran T.N., Lundholm C., Young C., Sparen P., Dahlstrom L.A. Acceptability of HPV vaccination among young adults aged 18-30 years-a population based survey in Sweden. Vaccine 2010, 28(47):7492-7500.
19. Ferris D.G., Cromwell L., Waller J.L., Horn L. Most parents do not think receiving human papillomavirus vaccine would encourage sexual activity in their children. J Low Genit Tract Dis 2010, 14(3):179-184.
20. Odoi-Agyarko H. Profile of reproductive health situation in Ghana 2003, World Health Organization.
21. World Health Statistics; 2006. http://www.who.int/whosis/en/.
22. Meekers D. Immaculate conceptions in Sub-Saharan Africa: exploratory analysis of inconsistencies in the timing of first sexual intercourse and first birth. Soc Biol 1995, 42(3-4):151-161.
23. Petaja T., keranen H., Karppa T., Kawa A., Lantela S., Siitari-Mattila M., et al. Immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in healthy boys aged 10-18 years. J Adolesc Health 2009, 44(1):33-40.
24. Centers for Disease Control and Prevention. Gardasil update: safety and efficacy in boys and men ACIP; 2009. Available from: http://www.cdc.gov/vaccines/recs/acip/downloads/mtg-slides-jun09/06-2-hpv.pdf.
25. Goldie S.J., O'Shea M., Campos N.G., Diaz M., Sweet S., Kim S.Y. Health and economic outcomes of HPV 16 18 vaccination in 72 GAVI-eligible countries. Vaccine 2008, 26(Jul 29 (32)):4080-4093.